Supplement 5 provides guidance for the movement and medical treatment of COVID-19 patients, symptomatic persons under investigation or those that have potentially been exposed to COVID-19.
FHP (Supplement 5) - DoD Guidance for Movement and Medical Treatment of COVID-19 Patientspdf